Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas
Downloads Digital Contract Notes Online Trading Demo News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Neuland Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code 524558 border-img ISIN Demat INE794A01010 border-img Book Value 1,081.52 border-img NSE Symbol NEULANDLAB border-img Div & Yield % 0.11 border-img Market Cap (₹ Cr.) 15818.55 border-img P/E 66.08 border-img EPS 186.59 border-img Face Value 10
ParticularsMar 2024
(₹)		Mar 2023
(₹)		Mar 2022
(₹)		Mar 2021
(₹)		Mar 2020
(₹)		Mar 2019
(₹)
INCOME :       
Sales Turnover 1558.581191.20951.08936.91762.71666.83
Excise Duty 0.000.000.000.000.000.00
Net Sales 1558.581191.20951.08936.91762.71666.83
Other Income 12.549.752.0816.093.893.49
Stock Adjustments 55.149.5115.411.2411.16-5.80
Total Income 1626.261210.46968.57954.24777.76664.52
EXPENDITURE :       
Raw Materials 636.49491.98441.79443.04394.41363.03
Power & Fuel Cost 48.7248.6242.2139.2132.7526.81
Employee Cost 248.53194.84175.76144.02118.48104.47
Other Manufacturing Expenses 103.7382.6984.9273.7161.7947.51
Selling & Administrative Expenses 104.2988.5070.5079.8051.7652.57
Miscellaneous Expenses 10.0422.779.1211.9313.218.76
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 1151.81929.40824.29791.71672.41603.16
Operating Profit 474.47281.06144.27162.54105.3461.36
Interest 14.0013.0713.4917.9021.5715.66
Gross Profit 460.47267.99130.78144.6483.7745.70
Depreciation 59.7052.7849.0439.6831.2825.86
Profit Before Tax 400.77215.2181.74104.9652.4919.84
Tax 99.5950.3920.4212.480.005.44
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 1.591.70-2.2212.1836.62-1.75
Reported Net Profit 299.60163.1263.5380.2915.8816.14
Extraordinary Items -0.30-0.66-1.369.810.12-0.09
Adjusted Net Profit 299.90163.7864.8970.4815.7616.23
Adjustment below Net Profit 0.000.000.000.00-0.180.00
P & L Balance brought forward 460.54303.84244.15166.42155.67139.53
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 12.836.413.852.574.950.00
P & L Balance carried down 747.31460.54303.84244.15166.42155.67
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 140.00100.0050.0050.0020.000.00
Dividend Per Share(Rs) 14.0010.005.005.002.000.00
Earnings Per Share-Unit Curr 232.24126.4449.2562.2412.3112.51
Earnings Per Share(Adj)-Unit Curr 232.24126.4449.2562.2412.3112.51
Book Value-Unit Curr 988.88765.49647.06605.44546.26538.54
Book Value(Adj)-Unit Curr 988.88765.49647.06605.44546.26538.54

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109, |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh